Clinical trial

Effectiveness of Topical 0.5% Levofloxacin to Reduce the Conjunctival Bacterial…

NCT00491049 · Ludwig-Maximilians - University of Munich, Other · Completed

Key facts

NCT number NCT00491049
Title Effectiveness of Topical 0.5% Levofloxacin to Reduce the Conjunctival Bacterial Flora Before Intraocular Surgery
Official title Phase 4 Study on Effectiveness of Topical 0.5% Levofloxacin on Reduction of Preoperative Conjunctival Flora in Patients Scheduled for Intraocular Surgery
Lead sponsor Ludwig-Maximilians - University of Munich, Other
Collaborators Santen Gmbh
Status Completed
Phase Phase 4
Study type Interventional
Conditions Conjunctival Bacterial Flora
Intervention type Drug
Interventions 0.5% levofloxacin eye drops
Enrollment 140
Start date Sep 1, 2004
Completion Apr 1, 2005
First posted Jun 25, 2007
Last update posted Jun 25, 2007
Countries Germany

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies